LIST OF FIGURES
FIGURE 53 CRISPR FORMED THE LARGEST TECHNOLOGY SEGMENT IN CANADA IN 2014 ....................................................... 94 FIGURE 54
FIGURE 55
BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES FORMED THE LARGEST END-USER SEGMENT IN CANADA IN 2014 ............................................................................................................... 95
CELL LINE ENGINEERING ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING APPLICATIONS MARKET IN EUROPE ............................................................................................ 97
FIGURE 56 CRISPR FORMED THE LARGEST TECHNOLOGY SEGMENT IN EUROPE IN 2014 ....................................................... 98 FIGURE 57
BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING MARKET IN EUROPE ................................................................... 99
FIGURE 58 ASIA : MARKET SNAPSHOT ........................................................................................................................................ 100 FIGURE 59 GENOME EDITING MARKET IN CHINA TO GROW AT HIGHEST CAGR IN THE FORECAST PERIOD ........................... 101 FIGURE 60
FIGURE 61
FIGURE 62
CELL LINE ENGINEERING SEGMENT DOMINATED THE GENOME EDITING APPLICATIONS MARKET IN ASIA IN 2014 ............................................................................................................... 102
CRISPR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING TECHNOLOGIES MARKET IN ASIA ............................................................................................................. 103
BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING MARKET IN ASIA ........................................................................ 104
FIGURE 63 CELL LINE ENGINEERING FORMED THE LARGEST APPLICATION SEGMENT IN JAPAN IN 2014 ............................. 105 FIGURE 64 CRISPR TECHNOLOGY SEGMENT HELD THE LARGEST SHARE OF THE MARKET IN JAPAN IN 2014 ..................... 106 FIGURE 65
BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING END-USERS MARKET IN JAPAN ................................................ 107
FIGURE 66 CELL LINE ENGINEERING WAS THE LARGEST APPLICATION SEGMENT IN CHINA IN 2014 ................................... 108 FIGURE 67 CRISPR HELD THE LARGEST SHARE OF THE MARKET IN CHINA IN 2014 ............................................................... 109 FIGURE 68
BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE GENOME EDITING MARKET IN CHINA ..................................................................... 110
FIGURE 69 CELL LINE ENGINEERING FORMED THE LARGEST APPLICATION SEGMENT IN INDIA ............................................ 111 FIGURE 70
FIGURE 71
FIGURE 72
FIGURE 73
CRISPR FORMED THE LARGEST AND THE FASTEST-GROWING TECHNOLOGY SEGMENT IN INDIA IN 2014 ...................................................................................................................................... 112
BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES FORMED THE LARGEST END-USER SEGMENT IN INDIA IN 2014 ............................................................................................ 113
CELL LINE ENGINEERING COMMANDED THE LARGEST SHARE OF THE ROA GENOME EDITING MARKET IN 2014 ......................................................................................................... 114
CRISPR TECHNOLOGY SEGMENT DOMINATED THE ROA MARKET FOR GENOME EDITING IN 2014 ........................................................................................................................................ 115
sales @ marketsandmarkets . com www . marketsandmarkets . com
21